PHARMATHENE, INC 4
4 · PHARMATHENE, INC · Filed Aug 4, 2015
Insider Transaction Report
Form 4
Runge Jeffrey W.
Director
Transactions
- Award
Stock option (right to buy)
2015-08-02+20,000→ 20,000 totalExercise: $1.69From: 2016-08-02Exp: 2025-08-01→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The Issuer's Board of Directors approved the stock option grant on a non-trading day. On July 31, 2015, the last trading day prior to the date of grant, the closing price of the Issuer's common stock was $1.69 per share.